• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A Nanomolar Multivalent Ligand as Entry Inhibitor of the Hemagglutinin of Avian Influenza

tetano

Editor, Senior Moderator
J Am Chem Soc. 2013 Dec 30. [Epub ahead of print]
A Nanomolar Multivalent Ligand as Entry Inhibitor of the Hemagglutinin of Avian Influenza.
Waldmann M, Jirmann R, Hoelscher K, Wienke M, Niemeyer FC, Rehders D, Meyer B.
Abstract

Influenza virus attaches itself to sialic acids on the surface of epithelial cells of the upper respiratory tract of the host using its own protein hemagglutinin. Species specificity of influenza virus is determined by the linkages of the sialic acids. Birds have alpha2-3 and humans alpha2-6 linked sialic acids, respectively. Viral hemagglutinin is a homo-trimeric receptor and thus tri- or oligovalent ligands should have a high binding affinity. We describe the in silico design, chemical synthesis and binding analysis of a trivalent glycopeptide mimetic. This compound binds to hemagglutinin H5 of avian influenza with a dissociation constant of KD=446 nM and an inhibitory constant of KI=15 microM. In silico modeling shows that the ligand should also bind to hemagglutinin H7 of the virus that causes the current influenza outbreak in China. The trivalent glycopeptide mimetic and analogues have the potential to block many different influenza viruses.

PMID:
24377426
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24377426
 
Back
Top Bottom